Cabio Biotech(Wuhan) News

Jia Biyou (688089): Short-term pressure on Q3 profits to plan asset restructuring

Oct 30, 2024 18:06

Jia Biyou (688089): Seize the layout opportunity and plan to acquire Ou Yi's shares

guoyuan securitiesOct 29, 2024 00:00

Jia Biyou (688089): Gross margin is under pressure due to revenue structure and plans to acquire Ou Yi Biotech

gtjaOct 29, 2024 00:00

Jia Biyou (688089): Performance is in line with expectations, overseas growth is impressive

Aug 28, 2024 14:31

Jia Biyou (688089): Household and Personal Goods/Essential Consumption Rating: Increase

Jul 15, 2024 16:11

Jia Biyou (688089): Gross margin improved year-on-year in Q1 beyond expectations

Apr 30, 2024 00:00

Jia Biyou (688089): 23-year results are in line with market expectations, 1Q24 profit margins have recovered

Apr 28, 2024 13:46

Guoyuan Securities released a research report on April 27 stating that it gave Jiabiyou (688089.SH) a purchase rating. The main reasons for the rating include: 1) revenue +33% in 2024Q1; 2) the implementation of the new national standard increased domesti

Zhitong FinanceApr 28, 2024 09:22

Jia Biyou (688089): A bright start to Q1, looking forward to more throughout the year

Apr 28, 2024 00:00

Jia Biyou (688089): Accelerating the expansion of overseas markets, new HMOS products are expected to launch

Apr 28, 2024 00:00

Jia Biyou (688089): Fundamentals are stabilizing, the trend is improving, synthetic biotechnology and new HMO products are ready to go

Mar 23, 2024 00:00

Jia Biyou (688089): Fourth quarter revenue pressure actively lays out overseas markets

Feb 26, 2024 11:26

Jiabiyou (688089): Month-on-month performance improvement, business inflection point imminent

Debon SecuritiesOct 31, 2023 00:00

Jabiyou (688089) 2023 Third Quarter Report Review: Q3 Revenue Increased 23%, Operations Improved Quarterly

GuoyuanOct 30, 2023 20:32

Jiabiyou (688089): Improved product structure, gradual implementation of overseas orders

CSCOct 29, 2023 11:52

Jiabiyou (688089): Continued month-on-month recovery in performance, focus on business progress

Cinda SecuritiesOct 29, 2023 00:00

Jia Biyou (688089) 2023 Interim Report Review: Q2 Revenue Increased 16%, Long-term Upward Logic Remain Unchanged

國元證券Sep 1, 2023 00:00

Jia Biyou (688089): Gross margin improved month-on-month, focus on the progress of overseas expansion

國泰君安Aug 27, 2023 00:00

Jia Biyou (688089): Performance is in line with expectations, reversal is beginning to shine

信達證券Aug 27, 2023 00:00

Jia Biyou (688089): DHA and domestic customers have performed excellently and are concerned about the progress of overseas business

中金公司Aug 27, 2023 00:00